Osteal Therapeutics

Dallas, TX · Founded 2013 · Privately Held (backing)

Developer of infection therapeutics designed to reduce the mortality, morbidity, and cost of care associated with musculoskeletal infections. Osteal Therapeutics is based in Dallas, TX and was founded in 2013. It was valued at $576 million at its later-stage round in Nov 2025, the last priced event on record. It has raised $133 million across 4 recorded rounds; the latest was a $15.6 million early-stage round in Oct 2025.

PMV mark · valuation
$575.6M
Oct 2026
Priced at
its later-stage round
Nov 2025
Total raised
$133.1M
Last round
Early Stage VC
Oct 2025
What is Osteal Therapeutics worth?
$575.6MPrivateMarketView mark · Oct 2026

Valued at $575.6M at its later-stage round, Nov 2025. Nothing has traded since.

Free account
More of Osteal Therapeutics with a free account
  • ·Watch Osteal Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Osteal Therapeutics funding history

4 rounds
DateRoundRaisedPost-money
Oct 2025Early Stage VC$15.6M▮
May 2024Early Stage VC$50.0M▮
Aug 2023Early Stage VC$22.3M▮
Dec 2021Early Stage VC$30.2M▮
Unlock post-money valuations

Membership and data by Private Market View

Osteal Therapeutics valuation

Osteal Therapeutics was valued at $576 million at its later-stage round in Nov 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Osteal Therapeutics raised?

Osteal Therapeutics has raised $133 million across 4 recorded rounds since 2021. The largest was a $50 million early-stage round in May 2024; the most recent was a $15.6 million early-stage round in Oct 2025.

Osteal Therapeutics has filed 3 Form Ds with the SEC since 2021, most recently in Jun 2024 ($50 million sold to 16 investors).

How Osteal Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Osteal Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Osteal Therapeutics

What is Osteal Therapeutics worth?
Osteal Therapeutics is valued at $575.6M as of Oct 2026. Valued at $575.6M at its later-stage round, Nov 2025. Nothing has traded since.
How much has Osteal Therapeutics raised?
Osteal Therapeutics has raised $133.1M in total funding across 4 recorded rounds.
When did Osteal Therapeutics last raise?
Osteal Therapeutics last raised in Oct 2025 (Early Stage VC), raising $15.6M.